IBRUTINIB
Natco launches cut price versions of cancer drug ibrutinib in indiaThe patent for the drug is held by Pharmacyclics for three to four more years in India. Pharmacyclics was globally acquired by US giant Abb...20 Dec, 2019, 07.52 AM IST
Illegal cancer drugs from Bangladesh flood local marketIllegal import of drugs from Bangladesh and other neighbouring countries have further added to the woes of pharmaceutical companies. Expert...18 Nov, 2019, 10.58 AM IST
New treatment for leukaemia could replace chemotherapyThe average survival time of these patients is between one and two years when they receive standard treatment.21 Mar, 2016, 06.04 PM IST
Load More